Gaurang Shah of Geojit Financial Services is of the view that one may prefer Aurobindo Pharma.
Gaurang Shah of Geojit Financial Services told CNBC-TV18, "Wockhardt would not be the stock that we would recommend. In fact some time back we had a sell recommendation. For one and a half - two year plus time horizon, Aurobindo Pharma would be the preferred stock which we would recommend.""We have being maintaining the positive view on Aurobindo for a very long time and in terms of earnings visibility too Aurobindo would be a better pick than Wockhardt," he said.